高风险大规模肺血栓栓塞的算法与体外膜氧化
Cagdas Baran1, Ahmet Kayan2, Canan Soykan Baran3
1Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, 06230 Ankara, Turkey.
Journal of clinical medicine
|November 27, 2024
概括
身体外膜氧化 (ECMO) 有效地支持接受手术的高风险大规模肺栓塞 (PE) 患者. ECMO稳定了血液动力学,有助于恢复,在这些关键病例中,住院死亡率低.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 大规模肺栓塞 (PE) 是一种导致急性呼吸和心力衰竭的危急疾病.
- 高风险的PE患者往往需要进行入侵性手术,如手术栓塞术或血栓切除术.
- 身体外膜氧化 (ECMO) 被探索为这些复杂病例的重要支持.
研究的目的:
- 评估ECMO在经过肺栓塞术或血栓切除术的高风险大量PE患者的疗效.
- 评估ECMO在血液动力学稳定和患者康复中的作用.
- 分析结果,包括干预后的死亡率和功能改善.
主要方法:
- 从2018年1月到2023年12月对27名高风险大规模PE患者的回顾性分析.
- 患者接受了手术栓塞切除术 (n=7) 或以导管为基础的血栓切除术 (n=5).
- 基于血液动力学不稳定性的ECMO (静脉动脉或静脉动脉静脉) 被启动.
主要成果:
- 20名患者接受了ECMO支持,7名患者需要手术内VA-ECMO,9名患者转换为VAV-ECMO.
- 在医院的死亡率为18.5% (n=5).
- 幸存者表现出显著的血液动力学和生化改善,包括增强的右心室功能和稳定的平均动脉压力.
结论:
- 对于高风险的大量PE患者,ECMO提供了至关重要的生命支持,这些患者接受了栓塞切除术或血栓切除术.
- 它有效地稳定了血液动力学,并促进了重症患者的康复.
- 需要进一步的研究,以优化患者选择和高风险PE管理的ECMO时间.
相关概念视频
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...